Table: Garna Biosciences -2025 group results

Carna Biosciences

10/02/2026 07:01

Feb 10 (Reuters)- 
          Garna Biosciences Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended       Year ended        Year to         NEXT   
               Dec 31, 2025     Dec 31, 2024     Dec 31, 2026      YEAR     
                  LATEST          YEAR-AGO         COMPANY        COMPANY   
                 RESULTS          RESULTS          FORECAST     H1 FORECAST 
  Sales          579 mln          636 mln          720 mln                  
                (-9.0 pct)      (-60.9 pct)      (+24.4 pct)                
  Operating     loss 2.07        loss 2.08        loss 2.03                 
  Recurring     loss 2.14        loss 2.08        loss 2.05                 
  Net
  Net           loss 2.17        loss 2.18        loss 2.09                 
  EPS        loss 113.62 yen  loss 121.64 yen  loss 108.95 yen              
  Ann Div          NIL              NIL              NIL                    
  -Q2 Div          NIL              NIL              NIL                    
  -Q4 Div          NIL              NIL              NIL                    
  
  NOTE - Garna Biosciences Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T